Vinorelbine (VNR) by alternating intravenous (IV)/oral administration plus cisplatinum (CP) followed by oral VNR as first-line therapy of advanced non-small cell lung cancer (ANSCLC)

被引：0
|
作者：
Sperandi, Francesca
Melotti, Barbara
Giaquinta, Stefania
Piana, Edera
Pavesi, Lorenzo
Da Prada, Gian Antonio
Lelli, Giorgio
Martoni, Andrea Angelo
机构：
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] S Maugeri Fdn, Pavia, Italy
[3] Arcispedale St Anna, Ferrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [1] Vinorelbine (VNR) by alternating intravenous (IV)/oral administration plus cisplatinum (CP) followed by oral VNR as first-line therapy of advanced non-small cell lung cancer (ANSCLC)
    Melotti, B.
    Sperandi, F.
    Giaquinta, S.
    Piana, E.
    Pavesi, L.
    Da Prada, G. A.
    Lelli, G.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI22 - XI22
  • [2] Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study
    Martoni, A. A.
    Melotti, B.
    Sperandi, F.
    Giaquinta, S.
    Piana, E.
    Pavesi, L.
    Da Pradab, G.
    Letti, G.
    LUNG CANCER, 2008, 60 (03) : 387 - 392
  • [3] Oral vinorelbine (vnr) in the management of elderly patients with advanced non small cell lung cancer (ansclc)
    Gebbia, V
    Arcara, C.
    Bajardi, E.
    Mancuso, G.
    Testa, A.
    Varvara, F.
    Russo, P.
    Maucen, M.
    Borsellino, N.
    ANNALS OF ONCOLOGY, 2007, 18 : 194 - 194
  • [4] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Farhat, Fadi S.
    Ghosn, Marwan G.
    Kattan, Joseph G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 235 - 242
  • [5] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Fadi S. Farhat
    Marwan G. Ghosn
    Joseph G. Kattan
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 235 - 242
  • [6] Epirubicine-vinorelbine (EV) intravenous combination followed by oral vinorelbine (VNR) as first-line treatment in advanced breast cancer (ABC) patients: A POLONORD Group study.
    Frontini, L
    Ardizzoia, A
    Giordano, M
    Fagnani, D
    Scanni, A
    Isa, L
    Scognamiglio, G
    Pressiani, T
    Colombo, I
    Bertolini, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 70S - 70S
  • [7] Vinorelbine (VNR) and concurrent thoracic radiation therapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)
    Portalone, L. I.
    Lombardi, A.
    Luca, F.
    Signora, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] First-line Oral Vinorelbine for Elderly or Unfit Patients With Advanced/metastatic Non-small Cell Lung Cancer
    Mansueto, G.
    Longo, F.
    Stumbo, L.
    De Filippis, L.
    Del Signore, E.
    Quadrini, S.
    Del Bene, G.
    Adua, D.
    Lapadula, V.
    Di Seri, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S280 - S280
  • [9] Second line chemotherapy with vinorelbine (VNR) in a selected group of patients with non small cell lung cancer (NSCLC) in progression after first line cisplatinum (CP) based regimen
    Guaraldi, M
    Martoni, A
    Panetta, A
    Mineo, M
    Pannuti, F
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 509 - 513
  • [10] Vinorelbine (VNR) and carboplatinum (CAR) in patients with stage IIIB/IV non-small cell lung cancer (NSCLC).
    von Bültzingslöwen, F
    ANNALS OF ONCOLOGY, 2000, 11 : 119 - 119
12345